Suppr超能文献

“疑似尿路上皮癌”细胞学分类的价值:一项涵盖337例患者的4年相关性研究。

The value of the "suspicious for urothelial carcinoma" cytology category: a correlative study of 4 years including 337 patients.

作者信息

Ton Nu Tuyet Nhung, Kassouf Wassim, Ahmadi-Kaliji Babak, Charbonneau Michele, Auger Manon, Brimo Fadi

机构信息

Department of Pathology, McGill University Health Center and McGill University, Montreal, Quebec, Canada.

出版信息

Cancer Cytopathol. 2014 Nov;122(11):796-803. doi: 10.1002/cncy.21449. Epub 2014 Jun 6.

Abstract

BACKGROUND

The terminology used in reporting urine cytology lacks uniformity and the significance of the "atypical" and "suspicious" categories is still not well established. This results in variable clinical follow-up and management of those cases. The authors sought to investigate the prognostic value of a diagnosis of "suspicious for high-grade urothelial carcinoma" (HGUCA).

METHODS

All cases with a "suspicious" or "positive" cytological diagnosis spanning 4 years were included and correlated with the subsequent biopsies obtained within 6 months of urine collection.

RESULTS

A total of 447 correlative events (57% positive and 43% suspicious) corresponding to 773 cytology specimens and 337 patients were included. The morphology of the "suspicious" cells was similar to what has recently been reported in the literature as "atypical urothelial cells, cannot exclude HGUCA." A "suspicious" diagnosis was more often rendered than a "positive" one in voided specimens (80% vs 65%, respectively). The mean interval between cytology and biopsy was 31 days. On follow-up, 92% of "suspicious" diagnoses (176 of 191 diagnoses) and 90% of "positive" diagnoses (230 of 256 diagnoses) were found to have a biopsy with a diagnosis of carcinoma (low grade or high grade). A diagnosis of HGUCA followed a "suspicious" and a "positive" diagnosis in 79% and 86% of cases, respectively.

CONCLUSIONS

A "suspicious" diagnosis as defined in the current study warrants close investigations and repeat biopsy to rule out HGUCA. In addition, the findings of the current study raise the question of the need for quantitative criteria for diagnosing HGUCA on cytology.

摘要

背景

尿液细胞学报告中使用的术语缺乏统一性,“非典型”和“可疑”类别细胞的意义仍未完全明确。这导致了这些病例的临床随访和管理存在差异。作者试图研究“可疑高级别尿路上皮癌”(HGUCA)诊断的预后价值。

方法

纳入所有在4年期间细胞学诊断为“可疑"或"阳性”的病例,并与尿液采集后6个月内获得的后续活检结果相关联。

结果

共纳入447例相关事件(57%为阳性,43%为可疑),对应773份细胞学标本和337例患者。“可疑”细胞的形态与最近文献中报道的“非典型尿路上皮细胞,不能排除HGUCA”相似。在排尿标本中,“可疑”诊断比“阳性”诊断更常见(分别为80%和65%)。细胞学检查与活检之间的平均间隔为31天。随访发现,92%的“可疑”诊断(191例诊断中的176例)和90%的“阳性”诊断(256例诊断中的230例)活检诊断为癌(低级别或高级别)。分别有79%和86%的病例在“可疑”和“阳性”诊断后被诊断为HGUCA。

结论

本研究中定义的“可疑”诊断需要密切检查并重复活检以排除HGUCA。此外,本研究结果提出了在细胞学上诊断HGUCA是否需要定量标准的问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验